Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A

Dendritic cell (DC) vaccines are a safe and effective means of inducing tumor immune responses, however, a better understanding of DC biology is required in order to realize their full potential. Recent advances in DC biology have identified a crucial role for cDC1 in tumor immune responses, making...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahoud, M. H., Radford, K. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Immunotherapy – Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920153/
https://www.ncbi.nlm.nih.gov/pubmed/33625943
http://dx.doi.org/10.1080/21645515.2021.1873056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920153/
https://www.ncbi.nlm.nih.gov/pubmed/33625943
http://dx.doi.org/10.1080/21645515.2021.1873056

Ejemplares similares